06108 PE Ratio & Valuation, Is 06108 Overvalued

Historical Valuation

NEW RAY MEDIC (06108) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of NEW RAY MEDIC (06108) is between -- to -- according to relative valuation method.

Relative Value

Fair Zone

-----

Current Price：0.21

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is NEW RAY MEDIC (06108) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

NEW RAY MEDIC (06108) has a current Price-to-Book (P/B) ratio of 0.16. Compared to its 3-year average P/B ratio of 0.58, the current P/B ratio is approximately -73.05% higher. Relative to its 5-year average P/B ratio of 0.58, the current P/B ratio is about -73.05% higher. NEW RAY MEDIC (06108) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -12.39%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -12.39%, the current FCF yield is about -100.00% lower.

Performance Decomposition

AI Analysis

Market capitalization of 06108 increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of 06108 in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is 06108 currently overvalued or undervalued?

What is NEW RAY MEDIC (06108) fair value?

06108's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of NEW RAY MEDIC (06108) is between to according to relative valuation method.

How does 06108's valuation metrics compare to the industry average?

The average P/S ratio for 06108's competitors is 0.00, providing a benchmark for relative valuation. NEW RAY MEDIC Corp (06108) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

What is the current P/B ratio for NEW RAY MEDIC (06108) as of Mar 06 2026?

As of Mar 06 2026, NEW RAY MEDIC (06108) has a P/B ratio of 0.16. This indicates that the market values 06108 at 0.16 times its book value.

What is the current FCF Yield for NEW RAY MEDIC (06108) as of Mar 06 2026?

As of Mar 06 2026, NEW RAY MEDIC (06108) has a FCF Yield of 0.00%. This means that for every dollar of NEW RAY MEDIC's market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for NEW RAY MEDIC (06108) as of Mar 06 2026?

As of Mar 06 2026, NEW RAY MEDIC (06108) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of NEW RAY MEDIC's expected earnings over the next 12 months.

What is the current Forward P/S ratio for NEW RAY MEDIC (06108) as of Mar 06 2026?

As of Mar 06 2026, NEW RAY MEDIC (06108) has a Forward P/S ratio of 0.00. This means the market is valuing 06108 at $0.00 for every dollar of expected revenue over the next 12 months.

06108 Valuation